Lung cancer may be different for men and women, but researchers ponder what to do?
Hede
Karyn
K
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001141:Aromatase / Q000097:blood; D014408:Biomarkers, Tumor / Q000097:blood; D016190:Carboplatin / Q000008:administration & dosage; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood* / Q000188:drug therapy / Q000201:enzymology / Q000453:epidemiology; D002986:Clinical Trials as Topic; D004967:Estrogens / Q000097:blood* / Q000378:metabolism; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000201:enzymology / Q000453:epidemiology; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage / Q000031:analogs & derivatives; D011099:Polyglutamic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D011379:Prognosis; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology; D016019:Survival Analysis; D014481:United States / Q000453:epidemiology
D014408:Biomarkers, Tumor; D004967:Estrogens; D011099:Polyglutamic Acid; D016190:Carboplatin; D001141:Aromatase; D017239:Paclitaxel; C509139:paclitaxel poliglumex